Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2024-07-15 00:00:00 ET · period of report 2024-07-11 · accession 0000950170-24-083712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-07-15 | 2024-07-11 | FDMT | Bizily Scott | CLO | S - Sale+OE | $25.00 | -1,996 | 6,781 | -23% | -$49.9K |
| DT | 2024-07-15 | 2024-07-11 | FDMT | Bizily Scott | CLO | M - OptEx | $15.78 | +1,996 | 8,777 | +29% | +$31.5K |
| DT | 2024-07-15 | 2024-07-11 | FDMT | Bizily Scott | CLO | M - OptEx | $0.00 | -1,996 | 23.0K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-11 | S | D | 1,996 | $25.00 | 6,781 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-11 | M | A | 1,996 | $15.78 | 8,777 | D | — | — | (F2) Reflects 5,044 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |
| 3 | Derivative | Stock Option (Right To Buy) | 2024-07-11 | M | D | 1,996 | $0.00 | 23,004 | D | $15.78 · — to 2032-01-31 | 1,996 Common Stock | (F3) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 1, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |